financetom
Business
financetom
/
Business
/
Market Chatter: Meta Platforms Begins Testing of Own AI Chips
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Meta Platforms Begins Testing of Own AI Chips
Mar 11, 2025 4:14 AM

06:53 AM EDT, 03/11/2025 (MT Newswires) -- Meta Platforms ( META ) has begun testing its own microchip design for training artificial intelligence systems, a step in its effort to reduce dependence on other chipmakers, Reuters reported Tuesday, citing unnamed sources.

The new chip, designed in collaboration with foundry Taiwan Semiconductor Manufacturer (TSMC) was made to process only AI-specific tasks, potentially making it more efficient than integrated graphics processing units produced by Nvidia (NVDA), the report said.

The company plans to increase production of the chips pending results of the testing, the report said.

Meta did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Recursion Pharmaceuticals Fiscal Q2 Loss Widens, Revenue Rises
Recursion Pharmaceuticals Fiscal Q2 Loss Widens, Revenue Rises
Aug 5, 2025
08:24 AM EDT, 08/05/2025 (MT Newswires) -- Recursion Pharmaceuticals ( RXRX ) reported fiscal Q2 loss Tuesday of $0.41 per diluted share, widening from a $0.40 loss a year earlier. Analysts polled by FactSet expected a $0.34 loss. Revenue for the quarter ended June 30 was $19.2 million, up from $14.4 million a year earlier. Analysts surveyed by FactSet expected...
Silicon Laboratories Fiscal Q2 Loss Narrows, Revenue Rises; Fiscal Q3 Guidance Issued
Silicon Laboratories Fiscal Q2 Loss Narrows, Revenue Rises; Fiscal Q3 Guidance Issued
Aug 5, 2025
08:25 AM EDT, 08/05/2025 (MT Newswires) -- Silicon Laboratories ( SLAB ) reported Tuesday its fiscal Q2 loss narrowed to $0.67 per diluted share, compared with a loss of $2.56 a year earlier. Analysts polled by FactSet expected $0.66 loss. Revenue for the quarter ended July 5 was $192.8 million, compared with $145.4 million a year earlier. Analysts surveyed by...
Alight's Q2 Adjusted Earnings From Continuing Operations Rise, Revenue Falls; Revises 2025 Revenue Projection
Alight's Q2 Adjusted Earnings From Continuing Operations Rise, Revenue Falls; Revises 2025 Revenue Projection
Aug 5, 2025
08:23 AM EDT, 08/05/2025 (MT Newswires) -- Alight (ALIT) reported Q2 adjusted earnings from cotinuing operations Tuesday of $0.10 per diluted share, up from $0.05 a year earlier. Analysts polled by FactSet expected $0.10. Revenue for the quarter ended June 30 was $528 million, down from $538 million a year earlier. Analysts surveyed by FactSet expected $523.8 million. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved